Last reviewed · How we verify

Triptergium Wilfordii — Competitive Intelligence Brief

Triptergium Wilfordii (Triptergium Wilfordii) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal immunosuppressant. Area: Immunology.

marketed Herbal immunosuppressant Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Triptergium Wilfordii (Triptergium Wilfordii) — Ministry of Health, China. Triptergium wilfordii extract suppresses immune cell activation and reduces inflammatory cytokine production through multiple pathways including NF-κB inhibition.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Triptergium Wilfordii TARGET Triptergium Wilfordii Ministry of Health, China marketed Herbal immunosuppressant
tripterygium wilfordii tripterygium wilfordii Zhi-Hong Liu, M.D. marketed Herbal immunosuppressant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal immunosuppressant class)

  1. Ministry of Health, China · 1 drug in this class
  2. Zhi-Hong Liu, M.D. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Triptergium Wilfordii — Competitive Intelligence Brief. https://druglandscape.com/ci/triptergium-wilfordii. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: